Search free mortgage software,mortgage calculator
 
Sales of GenScripts Anti-His Monoclonal Antibody Increase 600% in 2008  
Published:  8/27/2008 1:52:44 AM
Company Site:  http://www.genscript.com
Category:  biotechnology
Last View 5/14/2012 2:18:50 PM
PR Hits 175




Technology PR:

PISCATAWAY, N.J., Aug. 25, 2008 GenScript Corporation has once again proven its status as a reliable supplier of the highest quality biological reagents.

GenScript developed and manufactures a highly sensitive anti-His monoclonal antibody (cat # A00186) that recognizes polyhistidine tags placed at N-terminal, C-terminal, or internal regions of fusion proteins. Noticeably, this antibody also recognizes 4xHis- and 5xHis-tags. This means that even if the 6xHis-tag is only partially exposed, it will still be recognized and detected by this antibody.GenScripts anti-His monoclonal antibody is well-suited for Westerns, IHC, preparation of protein purification resins, beads, detection kits and other products. The antibody is also available in biotin and HRP-conjugated forms.

To demonstrate its high confidence in the sensitivity and quality of the anti-His, GenScript offers free 10 g samples of all three versions of this antibody.

Many biotech companies have already switched to GenScript as their sole supplier of anti-His antibodies. The popularity of GenScripts anti-His grows every month, leading to a more than 600% increase in anti-His sales since March 2008.

GenScript Corporation is a reliable outsourcing partner providing a wide array of services to augment all stages of drug discovery and biological reagent manufacturing processes, including high-quality gene synthesis and cloning, custom protein expression and purification, custom peptide synthesis and antibody development, custom stable cell line development, and a wide selection of biological reagents to life science researchers in industrial and academic settings. GenScript Corporation is headquartered in Piscataway, New Jersey.

###

For further information, please contact:
Sally Wang, Director of Sales
GENSCRIPT CORPORATION
(877) 436-7274
sallyw@GenScript.com
http://www.genscript.com/index.html


Home  
 



Related Technology PR News:

Preclinical Development of Monoclonal Antibodies and Related Biologicals Now on ReportsandReports - Dallas, TX: ReportsandReports announce it Will Carry the Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging technologies and new therapeutic candidates Market Research ..  (58 Views)

Bharatbook.com : Market analysis on Therapeutic MonoclonalAntibodies - Therapeutic Monoclonal Antibodies MarketsAntibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engin ..  (43 Views)




RSS Feed of new press releases                                                             Home        Feed Map        Submit Press Release        Contact 
Privacy Policy